Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit

After Esperion Therapeutics disclosed a conflict with Nexletol partner Daiichi Sankyo in an SEC filing earlier this month, the company has kicked it up a notch with a lawsuit claiming it's entitled to $300 million in milestone payments.